Medium impact
Varicose Vein Treatment
Regence BlueShield·Effective Oct 1, 2026
This is a NEW varicose vein treatment prior authorization policy effective October 1, 2026, establishing strict medical necessity criteria for coverage. Treatment now requires documented functional impairment with 3+ months of conservative therapy, specific vein measurements from imaging studies, and incompetence exceeding 0.5 seconds. Multiple ablation and sclerotherapy techniques are classified as investigational. Several procedures previously may have been covered without these requirements.